NPI: 1881965911 · RICHMOND, VA 23225 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 01/20/2012
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 01/20/2012 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 15,337 | $260K |
| 2019 | 15,507 | $272K |
| 2020 | 8,733 | $256K |
| 2021 | 11,482 | $224K |
| 2022 | 10,759 | $311K |
| 2023 | 8,996 | $467K |
| 2024 | 1,623 | $136K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 23,624 | 1,608 | $1.88M |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 20,618 | 1,193 | $22K |
| A4657 | Syringe, with or without needle, each | 6,504 | 1,264 | $12K |
| J1756 | Injection, iron sucrose, 1 mg | 5,537 | 1,056 | $5K |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 172 | 97 | $3K |
| J1270 | Injection, doxercalciferol, 1 mcg | 12,671 | 861 | $1K |
| 85048 | 693 | 392 | $161.74 | |
| 83970 | 704 | 371 | $104.49 | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 29 | 14 | $30.60 |
| 82728 | 321 | 166 | $7.25 | |
| 83550 | 312 | 167 | $5.33 | |
| 85041 | 680 | 382 | $4.18 | |
| 83540 | 312 | 167 | $3.96 | |
| 82108 | 240 | 126 | $2.49 | |
| G0008 | Administration of influenza virus vaccine | 20 | 13 | $1.85 |